Company: BIAF
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001840
Chunk: 931

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 9
Chunk 931
---
components of lease expense, which are included in selling, general and administrative expense and depreciation and amortization for
the year ended December 31, 2024, and 2023 are as follows:

SCHEDULE OF COMPONENTS OF LEASE EXPENSE

    Components
    of lease expense: 
    2024  
    2023 
  
    Amortization of right-of-use assets
    - finance lease 
    $384,971  
    $128,324 
  
    Interest on lease liabilities - finance lease 
     83,041  
     33,838 
  
    Operating lease cost 
     93,029  
     39,887 
  
    Total lease cost 
    $561,041  
    $202,049 

    Cash paid for amounts included in the measurement
    of lease liabilities: 

    Operating cash flows from finance leases 
    $361,181  
    $93,238 
  
    Operating cash flows from operating leases 
     133,605  
     32,489 

SCHEDULE OF BALANCE SHEET INFORMATION RELATING TO LEASES

    Operating
    leases: 
    2024  
    2023 
  
    Operating
    lease right-of-use, assets 
    $463,011  
    $370,312 
  
    Operating lease liability, current 
     127,498  
     94,708 
  
    Operating lease liability,
    non-current 
     342,098  
     283,001 
  
    Total operating lease
    liabilities 
    $469,596  
    $377,709 

    Financing
    leases: 
    2024  
    2023 
  
    Financing lease right-of-use assets,
    gross 
    $1,294,168  
    $1,294,168 
  
    Accumulated amortization 
     (513,296) 
     (128,324)
  
    Finance lease right-of-use
    assets, net 
    $780,872  
    $1,165,844 
  
    Financing lease liability, current 
     395,301  
     365,463 
  
    Financing lease liability,
    non-current 
     444,448  
     835,467 
  
    Total finance lease
    liabilities 
    $839,749  
    $1,200,